2025 Year in Review: Looking Ahead to Psychedelics in 2026 (Video) Post published:December 30, 2025 Post category:2025 Year in Review/Analysis/News/Pα+
2025 Year in Review: Psychedelics in 2025 (Video) Post published:December 23, 2025 Post category:2025 Year in Review/Analysis/News/Pα+
The Psychedelic News Feed: December 15 – 21, 2025 Post published:December 22, 2025 Post category:Psychedelic News Feed Archive
Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026 Medical Psilocybin Launch; Radial Scores $50M; Otsuka’s “Novel Serotonergic Agonists”; Psilocybin Accelerates Brain Tumour Growth in Mice; Texas’ $50M Ibogaine Study Consortium Post published:December 17, 2025 Post category:Psychedelic Bulletin/Pα+
The Psychedelic News Feed: December 8 – 14, 2025 Post published:December 15, 2025 Post category:Psychedelic News Feed Archive
The Psychedelic Practitioner Issue 2: Preparation Post published:December 11, 2025 Post category:News/The Psychedelic Practitioner
Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next Post published:December 10, 2025 Post category:Interviews/Pα+
The Psychedelic News Feed: December 1 – 7, 2025 Post published:December 9, 2025 Post category:Psychedelic News Feed Archive
Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout Plans Post published:December 5, 2025 Post category:Psychedelic Bulletin/Pα+
The View from D.C.: Psychedelic Politics, Blockers and Approvals on the Horizon Post published:December 3, 2025 Post category:Analysis/News/Pα+